In our post-SiCKO environment, as Americans look to Europe to see how the other side of the pond is faring in 21st century health care policy, it's important to know the facts.
To that end, CMPI (the public policy home of drugwonks.com) is pleased to offer a new omnibus overview of what the EU refers to as "Information to Patients" (ItP) -- "Who wants to know?"
"Who wants to know" is written by CMPI senior fellow Jacob Arfwedson. He's the chief of our Paris bureau. A Swede who speaks French and German and writes in English.
And he's controversial in any (and every) language.
To access "Who wants to know," go to www.cmpi.org and look under "research papers."
To that end, CMPI (the public policy home of drugwonks.com) is pleased to offer a new omnibus overview of what the EU refers to as "Information to Patients" (ItP) -- "Who wants to know?"
"Who wants to know" is written by CMPI senior fellow Jacob Arfwedson. He's the chief of our Paris bureau. A Swede who speaks French and German and writes in English.
And he's controversial in any (and every) language.
To access "Who wants to know," go to www.cmpi.org and look under "research papers."
